Raras
Buscar doenças, sintomas, genes...
Pseudohipoparatireoidismo
ORPHA:97593CID-10 · E20.1CID-11 · 5A50.1DOENÇA RARA

Pseudo-hipoparatireoidismo (PHP) é um grupo heterogêneo de distúrbios endócrinos caracterizados por função renal normal e resistência à ação do hormônio da paratireóide (PTH), manifestando-se com hipocalcemia, hiperfosfatemia e níveis elevados de PTH e que inclui os subtipos PHP tipo 1a (PHP-1a), PHP tipo 1b (PHP-1b), PHP tipo 1c (PHP-1c), PHP tipo 2 (PHP-2) e pseudopseudo-hipoparatireoidismo (PPHP).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Pseudo-hipoparatireoidismo (PHP) é um grupo heterogêneo de distúrbios endócrinos caracterizados por função renal normal e resistência à ação do hormônio da paratireóide (PTH), manifestando-se com hipocalcemia, hiperfosfatemia e níveis elevados de PTH e que inclui os subtipos PHP tipo 1a (PHP-1a), PHP tipo 1b (PHP-1b), PHP tipo 1c (PHP-1c), PHP tipo 2 (PHP-2) e pseudopseudo-hipoparatireoidismo (PPHP).

Pesquisas ativas
9 ensaios
23 total registrados no ClinicalTrials.gov
Publicações científicas
1.719 artigos
Último publicado: 2026 Apr

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.67
Italy
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E20.1
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
14 sintomas
📏
Crescimento
10 sintomas
🧠
Neurológico
8 sintomas
👁️
Olhos
4 sintomas
💪
Músculos
3 sintomas
🧬
Pele e cabelo
2 sintomas

+ 37 sintomas em outras categorias

Características mais comuns

Resposta diminuída ao teste de estímulo do hormônio do crescimento
Falange distal do polegar curta
Movimentos involuntários
Hipertensão
Compressão da medula espinhal
Estrabismo
87sintomas
Sem dados (87)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 87 características clínicas mais associadas, ordenadas por frequência.

Resposta diminuída ao teste de estímulo do hormônio do crescimentoDecreased response to growth hormone stimulation test
Falange distal do polegar curtaShort distal phalanx of the thumb
Movimentos involuntáriosInvoluntary movements
HipertensãoHypertension
Compressão da medula espinhalSpinal cord compression

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.719PubMed
Últimos 10 anos200publicações
Pico202252 papers
Linha do tempo
2026Hoje · 2026🧪 1993Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Not applicable.

GNAS-AS1Disease-causing germline mutation(s) inDesconhecido
LOCALIZAÇÃO

VIAS BIOLÓGICAS (10)
G alpha (s) signalling eventsProstacyclin signalling through prostacyclin receptorADORA2B mediated anti-inflammatory cytokines productionGPER1 signalingG alpha (i) signalling events
OUTRAS DOENÇAS (1)
pseudohypoparathyroidism type 1B
HGNC:HGNC:24872
GNASProtein ALEXDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May inhibit the adenylyl cyclase-stimulating activity of guanine nucleotide-binding protein G(s) subunit alpha which is produced from the same locus in a different open reading frame

LOCALIZAÇÃO

Cell membraneCell projection, ruffle

VIAS BIOLÓGICAS (10)
G alpha (s) signalling eventsProstacyclin signalling through prostacyclin receptorADORA2B mediated anti-inflammatory cytokines productionGPER1 signalingG alpha (i) signalling events
EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
1324.4 TPM
Tireoide
727.3 TPM
Hipotálamo
548.6 TPM
Brain Frontal Cortex BA9
501.2 TPM
Cérebro - Hemisfério cerebelar
474.1 TPM
OUTRAS DOENÇAS (12)
progressive osseous heteroplasiapituitary adenoma 3, multiple typespseudohypoparathyroidism type 1CMcCune-Albright syndrome
HGNC:4392UniProt:P84996
STX16Syntaxin-16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

SNARE involved in vesicular transport from the late endosomes to the trans-Golgi network

LOCALIZAÇÃO

Golgi apparatus membraneCytoplasm

VIAS BIOLÓGICAS (1)
Retrograde transport at the Trans-Golgi-Network
MECANISMO DE DOENÇA

Pseudohypoparathyroidism 1B

A disorder characterized by end-organ resistance to parathyroid hormone, hypocalcemia and hyperphosphatemia. Patients affected with PHP1B lack developmental defects characteristic of Albright hereditary osteodystrophy, and typically show no other endocrine abnormalities besides resistance to PTH.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
149.5 TPM
Fallopian Tube
148.2 TPM
Cervix Endocervix
137.1 TPM
Pituitária
137.1 TPM
Cérebro - Hemisfério cerebelar
136.7 TPM
OUTRAS DOENÇAS (1)
pseudohypoparathyroidism type 1B
HGNC:11431UniProt:O14662

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Calcitriol (CALCITRIOL)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

547 variantes patogênicas registradas no ClinVar.

🧬 GNAS-AS1: NM_016592.5(GNAS):c.138C>A (p.Ala46=) ()
🧬 GNAS-AS1: NM_016592.5(GNAS):c.195del (p.Asn66fs) ()
🧬 GNAS-AS1: NM_016592.5(GNAS):c.483G>C (p.Gln161His) ()
🧬 GNAS-AS1: NM_016592.5(GNAS):c.94C>G (p.Leu32Val) ()
🧬 GNAS-AS1: NM_016592.5(GNAS):c.720C>A (p.Ile240=) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 398 variantes classificadas pelo ClinVar.

179
219
Patogênica (45.0%)
VUS (55.0%)
VARIANTES MAIS SIGNIFICATIVAS
GNAS: NM_000516.7(GNAS):c.27del (p.Glu10fs) [Pathogenic]
GNAS: NM_000516.7(GNAS):c.585+1G>C [Pathogenic]
GNAS: NM_000516.7(GNAS):c.236del (p.Ala79fs) [Likely pathogenic]
STX16: NM_001001433.3(STX16):c.556+1G>A [Pathogenic]
CDH4: NC_000020.10:g.57331908_60789961del [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 25
·Pré-clínico15
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Pseudohipoparatireoidismo

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

5 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

23 ensaios clínicos encontrados, 9 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
446 papers (10 anos)
#1

A maternal exon H splice-site variant leading to pseudohypoparathyroidism type 1B with broad methylation defects in GNAS-differentially methylated regions.

Clinical epigenetics2026 Mar 16

The GNAS locus produces multiple transcripts, including the maternally derived, GNAS-H, and GNAS-NESP55 and the paternally derived GNAS-XL, GNAS-A/B, and GNAS-AS, all of which are expressed in specific tissues. GNAS-Gsα is biparentally expressed in most tissues and imprinted in several tissues, specifically, the proximal tubules, thyroid, gonads, and pituitary. These imprinted transcripts are regulated by five differentially methylated regions (GNAS-DMRs), and hypomethylation in the GNAS-A/B:TSS-DMR causes resistance to hormones, including parathyroid hormone, leading to pseudohypoparathyroidism type 1B (PHP1B). Sporadic PHP1B shows broad methylation defects in the GNAS-DMRs, whereas most familial PHP1B cases show localized methylation defects at the GNAS-A/B:TSS-DMR and GNAS-AS2:TSS-DMR. We identified an inherited maternal exon H variant that causes a GNAS methylation pattern typically observed in sporadic PHP1B. To determine the underlying genetic cause in this family, we conducted long-read sequencing (LRS). LRS revealed a maternal exon H variant together with methylation defects of CpGs in the GNAS-DMRs. To evaluate the association of the variant with this familial PHP1B, we established patient-derived induced pluripotent stem cells (iPSCs). Reverse-transcription PCR (RT-PCR) and quantitative RT-PCR in patient-derived iPSCs showed no expression of GNAS-NESP55 or GNAS-H and increased expression of GNAS-AS, together with hypermethylation of the GNAS-NESP:TSS-DMR and hypomethylation of the GNAS-AS1:TSS-DMR and GNAS-XL:Ex1-DMR. RNA sequencing revealed no abnormal GNAS transcripts in iPSCs established from patients. To determine whether loss of GNAS-H expression itself causes PHP1B, or whether methylation defects of the GNAS-DMRs, followed by loss of GNAS-H expression, result in PHP1B in this family, we conducted RT-PCR after demethylation treatment in patient-derived iPSCs. We detected biallelic expressed GNAS-NESP55 transcript and only paternally expressed GNAS-H transcript. These findings indicated impaired maternal GNAS-H transcription in the patients, regardless of the methylation levels in the GNAS-DMRs. Furthermore, amplicon LRS spanning the region from exon H to GNAS-AS exon 1 in 40 sporadic PHP1B patients showed that genomic variants in this region are infrequent. Loss of maternal GNAS-H transcript precedes the onset of abnormal methylation imprinting at the GNAS-DMRs and contributes to its establishment. We also revealed that LRS is useful for diagnosing and researching imprinting disorders.

#2

Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.

Medicine2026 Mar 13

Pseudohypoparathyroidism type 1B (PHP1B) is a rare endocrine disorder caused by epigenetic defects at the GNAS locus, leading to isolated renal resistance to parathyroid hormone (PTH). Although typically identified in childhood, adult-onset cases are uncommon and easily overlooked. This case highlights the diagnostic challenge of late-onset PHP1B and the critical role of methylation-specific testing. A 33-year-old man was referred for evaluation of incidentally detected hypocalcemia (serum calcium 5.9 mg/dL) during a routine health examination. He complained of mild paresthesia of the hands and eyelid twitching but had no family history of endocrine disorders and exhibited no phenotypic features of Albright hereditary osteodystrophy. Laboratory evaluation revealed persistent hypocalcemia (serum calcium 7.7 mg/dL) and markedly elevated PTH levels (284.2 pg/mL) despite correction of magnesium and vitamin D insufficiency. Standard sequencing of the GNAS and STX16 genes showed no pathogenic variants. However, methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) identified gain of methylation in the NESP55 region and loss of methylation in the AS, XL, and A/B differentially methylated regions confirming a diagnosis of sporadic PHP1B. The patient received oral calcium carbonate and cholecalciferol supplementation. Magnesium deficiency was corrected with oral magnesium oxide. The patient remained asymptomatic during follow-up with adequate calcium supplementation. Adult-onset PHP1B should be considered in the differential diagnosis of unexplained hypocalcemia with elevated PTH, even in the absence of Albright hereditary osteodystrophy. Because conventional sequencing cannot detect imprinting defects, epigenetic testing such as MS-MLPA is essential for definitive diagnosis. Increased awareness of atypical, late-onset presentations can aid in timely diagnosis and appropriate management.

#3

Automated bone age assessment in rare pediatric growth disorders: a comparative study using Deeplasia.

Frontiers in endocrinology2026

Bone age (BA) assessment is essential for monitoring growth and maturation and guiding therapeutic interventions. While deep learning (DL) models offer high-speed automated BA prediction, their generalizability to rare pathological and diagnostically complex populations remains a significant concern. This study aims to validate the open-source DL system Deeplasia on external data from pediatric patients with various syndromic, endocrine, and lysosomal storage disorders (LSDs) and to compare its accuracy and consistency against multiple expert human raters. We retrospectively assembled 1,138 hand radiographs from multiple centers, including patients with SHOX deficiency; Noonan syndrome; Silver-Russell syndrome; Ullrich-Turner syndrome; pseudohypoparathyroidism; congenital adrenal hyperplasia (CAH); precocious puberty and precocious pseudopuberty (cohort 1); mucopolysaccharidosis types I, II, III, IV, and VI; alpha-mannosidosis; and unclassified LSDs (cohort 2). For each radiograph, BA was evaluated using the Greulich and Pyle method by two to five human experts to obtain a mean BA reference. Model performance was assessed using the mean absolute error (MAE), root mean squared error (RMSE), and 1-year accuracy for each cohort and underlying conditions, sex, and age groups. Furthermore, Deeplasia's performance was compared with that of individual raters by testing each rater and the model against the remaining experts. Deeplasia achieved a mean MAE of 5.95 months, an RMSE of 8.01 months, and a 1-year accuracy of 89.9% for cohort 1 (endocrine and syndromic conditions). For cohort 2 (lysosomal storage disorders), Deeplasia achieved a mean MAE of 7.13 months, an RMSE of 9.56 months, and a 1-year accuracy of 81.2%. In direct comparisons between Deeplasia and individual raters tested against the remaining experts, Deeplasia outperformed all human raters. Deeplasia was validated as a highly consistent, robust, and reliable tool for BA assessment in complex cases. It demonstrated superior accuracy compared with individual human raters and may assist clinicians in BA evaluation.

#4

Cerebral Calcification and Treatment-Resistant Seizures: A Rare Syndromic Presentation of Pseudohypoparathyroidism-A Case Report.

AACE endocrinology and diabetes2026

Pseudohypoparathyroidism (PHP) has a varied presentation, ranging from biochemically detected hypocalcemia in asymptomatic individuals to treatment-refractory seizures. Features may develop over time. Hypocalcemia with recurrent seizures in adolescents indicates a cause other than a primary central nervous system cause, rather than hypoparathyroidism and pseudohypoparathyroidism being the endocrinological causes. We present a case of an adolescent girl with difficult-to-treat seizures and dystonic body movement whose diagnostic workup confirmed PHP. Phenotypically, she fit in Albright hereditary osteodystrophy. However, her hypothyroidism status and obesity are more in favor of PHP type 1a. After treatment with calcium and calcitriol, her symptoms and biochemical parameters improved. PHP is a rare disorder involving hormone resistance that disrupts calcium homeostasis, presenting with hypocalcemia, hyperphosphatemia, and high parathyroid hormone despite normal vitamin D3. Adolescents may solely present with seizures, which poses a diagnostic challenge. The basal ganglia calcification causing extrapyramidal symptoms should prompt evaluation for hypocalcemia and possible endocrine causes. PHP may be associated with Albright Hereditary Osteodystrophy, featuring short stature, obesity, brachydactyly, and low intelligence. PHP requires prompt diagnosis and treatment with calcium and calcitriol, which can fully reverse symptoms. This case emphasizes the importance of detecting PHP as a potential cause of treatment-refractory seizures in patients with hypocalcemia, underscoring timely management to prevent hypocalcemic complications and seizures.

#5

Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.

Hormones (Athens, Greece)2026 Mar

Disorders caused by GNAS gene variants, including pseudohypoparathyroidism (PHP) types 1a, 1b and 1c, and pseudo-pseudohypoparathyroidism (PPHP), present with complex imprinting and phenotypic variability. The gene's parent-of-origin expression pattern results in diverse clinical manifestations. We report a three-generation family harboring a heterozygous missense variant in GNAS (c.305 C > T, p.Ala102Val), classified as "likely pathogenic". The proband, a 29-year-old primigravida, and her mother displayed phenotypic features of Albright hereditary osteodystrophy (AHO) including short stature, brachydactyly, round face, and obesity. The proband was diagnosed with primary hypothyroidism at age 25. During pregnancy, her hormonal profile resembled PPHP rather than PHP 1a, with normocalcemia and elevated parathyroid hormone (PTH), potentially masked by pregnancy physiology. Her mother's phenotype was consistent with PPHP and exhibited elevated PTH due to vitamin D deficiency. The proband delivered a male neonate with normal birth parameters, but was later found to carry the familial GNAS variant. The neonate developed features of AHO, elevated PTH, and transient hypothyroidism, consistent with PHP 1a. Hormonal and calcium homeostasis remained stable with supplementation. This is, to the best of our knowledge, the first reported case of a three-generation family with a GNAS variant demonstrating an evolving phenotype during pregnancy and early life. Pregnancy-related physiological changes may counteract typical hormone resistance, complicating diagnosis. Our findings emphasize the importance of genetic counseling and longitudinal follow-up in GNAS-related disorders, particularly during reproductive planning and early infancy.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC1.199 artigos no totalmostrando 200

2026

A maternal exon H splice-site variant leading to pseudohypoparathyroidism type 1B with broad methylation defects in GNAS-differentially methylated regions.

Clinical epigenetics
2026

Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.

Medicine
2026

Automated bone age assessment in rare pediatric growth disorders: a comparative study using Deeplasia.

Frontiers in endocrinology
2026

Cerebral Calcification and Treatment-Resistant Seizures: A Rare Syndromic Presentation of Pseudohypoparathyroidism-A Case Report.

AACE endocrinology and diabetes
2026

​The association of GNAS defects with pro-inflammatory adipokine levels in pseudohypoparathyroidism type 1.

Journal of endocrinological investigation
2025

A Rare Familial Case of Pseudohypoparathyroidism Type 1b in Two Brothers Presenting With Recurrent Leg Cramps and Learning Difficulties.

Cureus
2025

Basal Ganglia Calcification With Treatment-Resistant Hypocalcaemia and Persistent Psychosis in an 18-Year-Old: A Case Report.

Cureus
2025

Pseudohypoparathyroidism Presenting With Recurrent Twitching: Challenges Making a Diagnosis in a Low-Resource Environment.

Case reports in endocrinology
2026

Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.

Hormones (Athens, Greece)
2025

Hypocalcemia Revisited: Thinking Outside the Box!

Cureus
2025

Late-Onset Pseudohypoparathyroidism: A Case Report.

Cureus
2025

Novel Variants and Clinical Heterogeneity in Pediatric Calcium Metabolism Disorders Identified Through High-Yield Tiered Genetic Testing in a Taiwanese Cohort.

Medicina (Kaunas, Lithuania)
2025

Multidimensional Characterisation of Eating Behaviour in Genetic Obesity: A Systematic Review.

Obesity facts
2025

Significance of GNAS mutations for morbid obesity in children.

Human genomics
2025

Imprinting and skeletal disorders: lessons from pseudohypoparathyroidism and related disorders.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Six cases of ectopic cutaneous ossification associated with GNAS gene variants.

European journal of dermatology : EJD
2025

Human diseases caused by homozygous PTH1R mutations.

Frontiers in endocrinology
2025

Pseudohypoparathyroidism type 1B mimicking gitelman syndrome: diagnostic pitfalls and molecular insights.

Frontiers in genetics
2025

Defective GNAS imprinting due to splice site variants in pseudohypoparathyroidism type 1B.

JCI insight
2025

Pseudohypoparathyroidism with normocalcemia: a rare case report from Nepal.

Annals of medicine and surgery (2012)
2025

Natural History of Hyperphagia in Patients with Pseudohypoparathyroidism.

Journal of clinical medicine
2025

Clinical evaluation and molecular analysis of genetic and epigenetic inactivation defects in GNAS in children: A multicenter experience in China.

European journal of endocrinology
2025

Multi-locus methylation analyses reveal GNAS methylation defects in three patients with the Beckwith-Wiedemann syndrome phenotype and no molecular defects in the 11p15.5 imprinted region.

Clinical epigenetics
2025

A Splice-Region Variant Causes an Atypical Presentation of GNAS Inactivation Disorder.

American journal of medical genetics. Part A
2025

Analysis of the prevalence and incidence of pseudohypoparathyroidism in Poland based on National Health Fund data with clinical presentation of own cases.

Frontiers in endocrinology
2025

Loss-of-function Gαs rare disease variants exert mutation-specific effects on GPCR signaling.

Science signaling
2025

Alpha-smooth muscle actin-expressing dermal sheath cells are a major cellular contributor to heterotopic subcutaneous ossifications in a mouse model of Albright hereditary osteodystrophy.

JBMR plus
2025

Atypical presentation of pseudohypoparathyroidism with absence of mutations in the GNAS gene: a case report.

BMC endocrine disorders
2025

Bidirectional disruption of GNAS transcripts causes broad methylation defects in pseudohypoparathyroidism type 1B.

Proceedings of the National Academy of Sciences of the United States of America
2025

Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.

Endocrine reviews
2025

Germline-derived GNAS-Gsα variants associated with both gain-of-function and loss-of-function phenotypes.

European journal of endocrinology
2025

Pseudohypoparathyroidism: Challenges in Early Recognition and Diagnosis of a Rare Hereditary Disorder.

Cureus
2025

Hypocalcemic Tetany Transiently "Cured" by Pregnancy: A Case Report.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

Obesity with developmental delay in infancy: a rare cause not to miss-pseudohypoparathyroidism.

BMJ case reports
2025

Diagnostic Imaging of Primary Cutaneous Osteoma of the Forehead.

Case reports in dermatology
2025

A biallelically active embryonic enhancer dictates GNAS imprinting through allele-specific conformations.

Nature communications
2025

Pseudohypoparathyroidism Type 1b with Digital Clubbing.

Internal medicine (Tokyo, Japan)
2025

Pseudohypoparathyroidism type 1A presenting as short stature and congenital hypothyroidism.

Endocrinology, diabetes &amp; metabolism case reports
2025

A rare case of acrodysostosis type 2 with PDE4D mutation in a young female: a case report.

Oxford medical case reports
2025

The Endocrine Chameleon: Expanding the Phenotype of Pseudohypoparathyroidism 1A in Infancy.

Hormone research in paediatrics
2025

[Clinical and genetic characteristics analysis of two children with comorbidity of two rare genetic diseases].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Heterodisomy in the GNAS locus is also a cause of pseudohypoparathyroidism type 1B (iPPSD3).

Frontiers in endocrinology
2024

gnas Knockdown Induces Obesity and AHO Features in Early Zebrafish Larvae.

International journal of molecular sciences
2024

Bone Microstructure and Bone Strength Among Patients with Pseudohypoparathyroidism.

Calcified tissue international
2024

Recurrent small variants in NESP55/NESPAS associated with broad GNAS methylation defects and pseudohypoparathyroidism type 1B.

JCI insight
2024

Fahr's Syndrome with Pseudohypoparathyroidism: Oral Features and Genetic Insights.

International journal of molecular sciences
2024

Sensory Processing Challenges in Children with Neurodevelopmental Disorders and Genetic Conditions: An Observational Study.

NeuroSci
2024

Genotype-Phenotype Correlation of GNAS Gene: Review and Disease Management of a Hotspot Mutation.

International journal of molecular sciences
2024

Case report: Familial hypoparathyroidism with elevated parathyroid hormone due to an inactivating PTH mutation.

Frontiers in endocrinology
2025

[The importance of early diagnosis in pseudohypoparathyroidism. Review of the topic and clinical - radiological findings in a case of pseudohypoparathyroidism 1 A with late presentation].

Revista espanola de geriatria y gerontologia
2024

Vitamin D-dependent Rickets Type 1A Mimicking Pseudohypoparathyroidism in Presence of Active Tuberculosis.

JCEM case reports
2024

A Curious Case of Severe Recurrent Hypocalcemia.

Cureus
2024

Eiken syndrome with parathyroid hormone resistance due to a novel parathyroid hormone receptor type 1 mutation: clinical features and functional analysis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2024

Prevalence of hearing loss in pseudohypoparathyroidism.

Orphanet journal of rare diseases
2024

Pseudohypoparathyroidism leading to bilateral hip fracture: A case report.

Radiology case reports
2024

Albright's Hereditary Osteodystrophy: A Rare Genetic Disorder Diagnosed on Standard Radiography.

Journal of the Belgian Society of Radiology
2024

Growth Hormone Deficiency in an Adolescent With Pseudohypoparathyroidism Type 1B.

JCEM case reports
2025

Characterization of Digestive Manifestations in Patients with Impaired PTH/PTHrP Signaling Disorder/Pseudohypoparathyroidism.

Hormone research in paediatrics
2024

A Novel Maternally Inherited GNAS Variant in a Family With Hyperphagia and Obesity: 3 Cases.

JCEM case reports
2024

A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report.

Open life sciences
2024

STX16 exon 5-7 deletion in a patient with pseudohypoparathyroidism type 1B.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Pseudohypoparathyroidism type 1B with involuntary movements: a case report and literature review.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2024

Induced pluripotent stem cells derived renal tubular cells from a patient with pseudohypoparathyroidism and its response to parathyroid hormone stimulation.

Molecular biology reports
2024

Teaching NeuroImage: A 9-Year-Old Boy With Pseudohypoparathyroidism.

Neurology
2025

High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes.

The Journal of clinical endocrinology and metabolism
2024

Pseudohypoparathyroidism Type IB with Subclinical Hypothyroidism: a Pedigree Investigation and Literature Review.

Diabetes, metabolic syndrome and obesity : targets and therapy
2024

Cutaneous Calcified Mass of Foot in Pseudohypoparathyoidism: Case Report.

Medicina (Kaunas, Lithuania)
2024

Identification of a novel GNAS mutation in a family with pseudohypoparathyroidism type 1A.

BMC pediatrics
2024

A novel GNAS-Gsα splice donor site variant in a girl with pseudohypoparathyroidism type 1A and her mother with pseudopseudohypoparathyroidism.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2024

The Diagnosis of Albright's Osteodystrophy in a Case With Respiratory Failure.

Cureus
2024

Medulloblastoma in a child with osteoma cutis - a rare association due to loss of GNAS expression.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Vara Deformity and Subluxed Humeral Heads: An Unusual Sign in Pseudohypoparathyroidism.

Cureus
2024

Epileptic seizures and abnormal tooth development as primary presentation of pseudohypoparathyroidism type 1B.

BMJ case reports
2024

Novel 4.18 Mb deletion resulting in 2q37 microdeletion syndrome combined with PTH resistance found in one Chinese patient.

Endocrine
2024

Diagnosis and approach of pseudohypoparathyroidism type 1A and related disorders during long term follow-up: a case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Rare case in Somalia: Fahr's syndrome.

Annals of medicine and surgery (2012)
2024

GNAS AS2 methylation status enables mechanism-based categorization of pseudohypoparathyroidism type 1B.

JCI insight
2024

A Comprehensive Review of Syndromic Forms of Obesity: Genetic Etiology, Clinical Features and Molecular Diagnosis.

Current obesity reports
2024

Osteoma cutis in pseudohypoparathyroidism type 1A.

QJM : monthly journal of the Association of Physicians
2024

Interpreting epigenetic causes of recurrent hypokalemia and seizures: Gitelman syndrome co-exist with pseudohypoparathyroidism type 1B.

Nephrology (Carlton, Vic.)
2023

C-Cell Hyperplasia and Cystic Papillary Thyroid Carcinoma in a Patient with Type 1B Pseudohypoparathyroidism and Hypercalcitoninaemia: Case Report and Review of the Literature.

Journal of clinical medicine
2024

The role of genetic and epigenetic GNAS alterations in the development of early-onset obesity.

Mutation research. Reviews in mutation research
2024

Intrafamilial phenotypic heterogeneity in siblings with pseudohypoparathyroidism 1B due to maternal STX16 deletion.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

Recurrent transient severe hypocalcaemia in two siblings with type 1 Bartter syndrome.

Nephrology (Carlton, Vic.)
2023

A Case of Genetically Confirmed Pseudohypoparathyroidism Type 1a Presented with Multifocal Plate-Like Osteoma Cutis and Review of Literature.

Annals of dermatology
2023

Fahr Syndrome Secondary to Pseudohypoparathyroidism.

JCEM case reports
2023

(Epi)genetic and clinical characteristics in 84 patients with pseudohypoparathyroidism type 1B.

European journal of endocrinology
2023

Explorative research on glucolipid metabolism and levels of adipokines in pseudohypoparathyroidism type 1 patients.

Orphanet journal of rare diseases
2023

A Case of Pseudohypoparathyroidism Misdiagnosed as Idiopathic Epilepsy for 5 Years: Clinical Analysis and Follow-up Outcomes.

The Journal of international medical research
2023

Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study.

Seminars in arthritis and rheumatism
2024

Pseudohypoparathyroidism: complex disease variants with unfortunate names.

Journal of molecular endocrinology
2024

Benign Recurrent Aseptic Meningitis Complicated by Pseudohypoparathyroidism: A Case Report.

Clinical pediatrics
2023

GNAS locus: bone related diseases and mouse models.

Frontiers in endocrinology
2023

Rare Case of Pseudohypoparathyroidism With Normocalcemia Because of a Novel GNAS Mutation.

JCEM case reports
2023

Bartter Syndrome Type 1 Due to Novel SLC12A1 Mutations Associated With Pseudohypoparathyroidism Type II.

JCEM case reports
2024

Venous Thrombosis in a Pseudohypoparathyroidism Patient with a Novel GNAS Frameshift Mutation and Complete Resolution of Vascular Calcifications with Acetazolamide Treatment.

Hormone research in paediatrics
2023

Parathyroid Hormone Resistance: An Uncommon Cause of Hypocalcaemia in an Adult Ghanaian Female.

West African journal of medicine
2023

Pseudohypoparathyroidism versus signaling disorder: A case report.

SAGE open medical case reports
2023

Application of calcium-to-phosphorus (Ca/P) ratio in the diagnosis of pseudohypoparathyroidism: another piece in the puzzle of diagnosis of Ca-P metabolism disorders.

Frontiers in endocrinology
2023

Genotype-phenotype correlations in pseudohypoparathyroidism type 1a patients: a systemic review.

European journal of endocrinology
2023

Acute coronary syndrome with severe coronary calcification in a patient with pseudo-pseudohypoparathyroidism.

Journal of cardiology cases
2023

A case report of a patient with primary familial brain calcification with a PDGFRB genetic variant.

Frontiers in neurology
2023

Overweight and obesity in children and adolescents with endocrine disorders.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
2024

Clinical and Molecular Characteristics and Long-term Follow-up of Children With Pseudohypoparathyroidism Type IA.

The Journal of clinical endocrinology and metabolism
2023

Odyssey of a Misclassified Genomic Variant: Insight from an Incidental Finding Assessment.

Child neurology open
2024

Multiple brown tumors: a bone complication due to long-term untreated pseudohypoparathyroidism.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2023

Co-occurrence of Beckwith-Wiedemann syndrome and pseudohypoparathyroidism type 1B: coincidence or common molecular mechanism?

Frontiers in cell and developmental biology
2024

Maternal Imprinting in Pseudohypoparathyroidism - A Very Rare GNAS Gene Mutation Follows the Pattern.

Indian journal of pediatrics
2023

Vitamin D deficiency in adulthood: Presentation of 2familial cases simulating pseudohypoparathyroidism.

Medicina clinica
2023

Nutrition recommendations for patients with pseudohypoparathyroidism.

Anales de pediatria
2023

Genetic Obesity Disorders: Body Mass Index Trajectories and Age of Onset of Obesity Compared with Children with Obesity from the General Population.

The Journal of pediatrics
2023

Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.

European journal of endocrinology
2023

Craniosynostosis in primary metabolic bone disorders: a single-institution experience.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2023

Spectrum of Disorders associated with Tetany.

The Journal of the Association of Physicians of India
2023

GNAS gene mutations affecting XLαs and bone health: A long neglected relationship.

Clinical genetics
2023

Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism.

The Journal of clinical endocrinology and metabolism
2022

Fahr´s Syndrome; Pseudohypoparathyroidism Type Ib Masquerading as Epileptic Seizures.

Kathmandu University medical journal (KUMJ)
2023

Variable Bone Phenotypes in Patients with Pseudohypoparathyroidism.

Current osteoporosis reports
2023

Infant With Pseudohypoparathyroidism Type 1a, Misdiagnosed as Congenital Hypothyroidism.

Medical archives (Sarajevo, Bosnia and Herzegovina)
2023

A Rare Observation of Brachymetacarpia and Brachymetatarsia in a Patient with Primary Idiopathic Hypoparathyroidism.

Case reports in endocrinology
2023

The long-range interaction between two GNAS imprinting control regions delineates pseudohypoparathyroidism type 1B pathogenesis.

The Journal of clinical investigation
2023

Structural and Functional Implication of Natural Variants of Gαs.

International journal of molecular sciences
2023

A Novel GNAS Mutation in a Patient with Ia Pseudohypoparathyroidism (iPPSD2) Phenotype.

Genes
2023

Severe early-onset overgrowth in a case of pseudohypoparathyroidism type 1b, caused by STX16 deletion.

American journal of medical genetics. Part A
2023

Homozygous Ser-1 to Pro-1 mutation in parathyroid hormone identified in hypocalcemic patients results in secretion of a biologically inactive pro-hormone.

Proceedings of the National Academy of Sciences of the United States of America
2023

Parathyroid diseases and metabolic syndrome.

Journal of endocrinological investigation
2023

Atrophic macules containing mesenchymal cells are precursor lesions of osteoma cutis in Albright hereditary osteodystrophy.

Journal of cutaneous pathology
2022

Frequency of de novo variants and parental mosaicism in families with inactivating PTH/PTHrP signaling disorder type 2.

Frontiers in endocrinology
2023

Whole-genome sequencing revealed a novel long-range deletion mutation spanning GNAS in familial pseudohypoparathyroidism.

Molecular genetics &amp; genomic medicine
2023

Prevalence of Chiari malformation type 1 is increased in pseudohypoparathyroidism type 1A and associated with aberrant bone development.

PloS one
2023

One half-century of advances in the evaluation and management of disorders of bone and mineral metabolism in children and adolescents.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Basal ganglia calcification: pseudohypoparathyroidism with short fourth metacarpals.

Practical neurology
2023

[Analysis of GNAS gene variant in a Chinese pedigree affected with pseudohypoparathyroidism].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Complete Pseudo-Anodontia in an Adult Woman with Pseudo-Hypoparathyroidism Type 1a: A New Additional Nonclassical Feature?

Diagnostics (Basel, Switzerland)
2022

Pseudohypoparathyroidism during pregnancy and the postpartum period: A case series of five patients.

Frontiers in endocrinology
2022

Clinical and genetic characteristics for 4 patients with Type Ib pseudohypoparathyroidism.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2022

Pathogenic variants of the GNAS gene introduce an abnormal amino acid sequence in the β6 strand/α5 helix of Gsα, causing pseudohypoparathyroidism type 1A and pseudopseudohypoparathyroidism in two unrelated Japanese families.

Bone reports
2022

Sporadic pseudohypoparathyroidism type 1B due to methylation abnormality combined with hypokalemia: A case report and review.

Annales d'endocrinologie
2022

PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond.

Frontiers in endocrinology
2022

Full-length versus intact PTH concentrations in pseudohypoparathyroidism type 1 and primary hyperparathyroidism: clinical evaluation of immunoassays in individuals from China.

Endocrine
2022

New insights into thyroid dysfunction in patients with inactivating parathyroid hormone/parathyroid hormone-related protein signalling disorder (the hormonal and ultrasound aspects): One-centre preliminary results.

Frontiers in endocrinology
2022

Paroxysmal Dyskinesia in a case of Hypocalcemia with Hypothyroidism and Pseudohypoparathyroidism.

Annals of Indian Academy of Neurology
2023

Prevalence of Pseudohypoparathyroidism and Nonsurgical Hypoparathyroidism in Japan in 2017: A Nationwide Survey.

Journal of epidemiology
2022

[Pseudohypoparathyroidism and variants: A translational medicine success story].

Medecine sciences : M/S
2022

Acrodysostosis and pseudohypoparathyroidism (PHP): adaptation of Japanese patients with a newly proposed classification and expanding the phenotypic spectrum of variants.

Endocrine connections
2022

Characterizing Cerebral Imaging and Electroclinical Features of Five Pseudohypoparathyroidism Cases Presenting with Epileptic Seizures.

Behavioural neurology
2022

Delayed diagnosis of pseudohypoparathyroidism type 1a with rare hypothyroidism since childhood.

Oxford medical case reports
2022

A patient with pseudohypoparathyroidism type 1A previously misdiagnosed as hereditary multiple exostosis: A case report.

Experimental and therapeutic medicine
2022

GNAS mutation is an unusual cause of primary adrenal insufficiency: a case report.

BMC pediatrics
2022

Resting Energy Expenditure and Body Composition in Children and Adolescents With Genetic, Hypothalamic, Medication-Induced or Multifactorial Severe Obesity.

Frontiers in endocrinology
2022

Different AHO phenotype in a Chinese family with a novel GNAS missense variant: a case report.

Italian journal of pediatrics
2022

Fahr's Disease and Hypoparathyroidism - A Missing Link.

Neurology India
2022

Familial Pseudohypoparathyroidism Type IB Associated with an SVA Retrotransposon Insertion in the GNAS Locus.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2022

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance.

Frontiers in endocrinology
2022

Targeted Long-Read Sequencing Identifies a Retrotransposon Insertion as a Cause of Altered GNAS Exon A/B Methylation in a Family With Autosomal Dominant Pseudohypoparathyroidism Type 1b (PHP1B).

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2022

Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or Pseudohypoparathyroidism.

JBMR plus
2022

Pseudohypoparathyroidism: a diagnosis to consider once a PTH elevation is detected.

Acta bio-medica : Atenei Parmensis
2022

Novel genetic variants of KHDC3L and other members of the subcortical maternal complex associated with Beckwith-Wiedemann syndrome or Pseudohypoparathyroidism 1B and multi-locus imprinting disturbances.

Clinical epigenetics
2022

Early Diagnosis of Pseudohypoparathyroidism before the Development of Hypocalcemia in a Young Infant.

Children (Basel, Switzerland)
2022

Fahr syndrome discovered in adulthood revealing a rare GNAS mutation in pseudohypoparathyroidism type 1a in a Tunisian family.

Clinical case reports
2022

Albright's hereditary osteodystrophy: an entity to recognize.

Rheumatology (Oxford, England)
2022

Tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1a.

Bone reports
2022

Clinical and genetic analysis of pseudohypoparathyroidism complicated by hypokalemia: a case report and review of the literature.

BMC endocrine disorders
2022

Paroxysmal Kinesigenic Dyskinesia Secondary to Pseudohypoparathyroidism Responding to Correction of Calcium.

Movement disorders clinical practice
2022

Novel multilocus imprinting disturbances in a child with expressive language delay and intellectual disability.

American journal of medical genetics. Part A
2022

A novel GNAS variant presents with disorders of GNAS inactivation and cardiomyopathy.

American journal of medical genetics. Part A
2022

Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.

BMC endocrine disorders
2022

Intracranial calcifications in pseudohypoparathyroidism type 1b: Report of four cases.

Endocrinologia, diabetes y nutricion
2022

Aberrant Bone Regulation in Albright Hereditary Osteodystrophy dueto Gnas Inactivation: Mechanisms and Translational Implications.

Current osteoporosis reports
2022

Intralesional sodium thiosulfate treatment of calcinosis cutis in pseudopseudohypoparathyroidism.

Pediatric dermatology
2022

A novel variant in the GNAS complex locus causes Albright hereditary osteodystrophy with pseudopseudohypoparathyroidism.

JAAD case reports
2022

A complex pheotype in a girl with a novel heterozygous missense variant (p.Ile56Phe) of the GNAS gene.

Orphanet journal of rare diseases
2022

Novel PTH Gene Mutations Causing Isolated Hypoparathyroidism.

The Journal of clinical endocrinology and metabolism
2022

Pseudohypoparathyroidism type 1 B mimicking Fahr's disease in a 28-year-old female: A case report.

Clinical case reports
2024

Autosomal dominant pseudohypoparathyroidism type 1b due to STX16 deletion: a case presentation and literature review.

Minerva endocrinology
2022

A novel deletion involving the first GNAS exon encoding Gsα causes PHP1A without methylation changes at exon A/B.

Bone
2022

Parental Origin of Gsα Inactivation Differentially Affects Bone Remodeling in a Mouse Model of Albright Hereditary Osteodystrophy.

JBMR plus
2022

Genetics of monogenic disorders of calcium and bone metabolism.

Clinical endocrinology
2022

Novel Pathogenetic Variants in PTHLH and TRPS1 Genes Causing Syndromic Brachydactyly.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2022

Pseudohypoparathyroidism type 1a caused by a GNAS gene mutation: over 40 years without a proper diagnosis.

Polish archives of internal medicine
2022

Lack of GNAS Remethylation During Oogenesis May Be a Cause of Sporadic Pseudohypoparathyroidism Type Ib.

The Journal of clinical endocrinology and metabolism
2021

Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor.

The New England journal of medicine
2021

Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism.

Journal of the Endocrine Society
2022

Sporadic Pseudohypoparathyroidism Type 1B in Monozygotic Twins: Insights Into the Pathogenesis of Methylation Defects.

The Journal of clinical endocrinology and metabolism
2021

Molecular genetic analysis and growth hormone response in patients with syndromic short stature.

BMC medical genomics
2021

A unique case of bilateral triceps avulsion fracture in a patient with pseudohypoparathyroidism.

Shoulder &amp; elbow
2021

Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study.

Orphanet journal of rare diseases
2021

Obesity-Associated GNAS Mutations and the Melanocortin Pathway.

The New England journal of medicine
2021

Hormone resistance in children: what primary care physicians need to know.

Acta bio-medica : Atenei Parmensis
2021

Brachydactyly in Pseudopseudohypoparathyroidism.

Mayo Clinic proceedings
2022

Progression of PTH Resistance in Autosomal Dominant Pseudohypoparathyroidism Type Ib Due to Maternal STX16 Deletions.

The Journal of clinical endocrinology and metabolism
2021

Preoperative matching studies in the diagnosis of parathyroid adenoma for primary hyperparathyroidism: Can we avoid intraoperative PTH monitoring?

Cirugia espanola
2021

Pseudohypoparathyroidism mimicking cervical diffuse idiopathic skeletal hyperostosis with dysphagia: A case report and literature review.

Bone reports
2021

Is All Hypocalcemia Due to Low Parathyroid Hormone?: An Unusual Case of Pseudohypoparathyroidism in a Young and Healthy Patient.

Cureus
2021

Hypocalcemia as a Cause of Complex Febrile Seizures in a Toddler.

Case reports in pediatrics
2022

Central Precocious Puberty in a Boy with Pseudohypoparathyroidism Type 1A due to a Novel GNAS Variant, with Congenital Hypothyroidism as the First Manifestation.

Journal of clinical research in pediatric endocrinology
2022

A Case of Sporadic Pseudohypoparathyroidism Type 1B Presented with Hypokalemia.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
2021

[Respiratory impairment in a patient with acrodysostosis: A rare association of an uncommon pathology].

Archivos argentinos de pediatria
2021

A Distinct Variant of Pseudohypoparathyroidism (PHP) First Characterized Some 41 Years Ago Is Caused by the 3-kbSTX16 Deletion.

JBMR plus
2021

Mild progressive osseous heteroplasia overlap syndrome with PTH and TSH resistance appearing during adolescence and not early childhood.

Endocrine
Ver todos os 1.199 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Pseudohipoparatireoidismo.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Pseudohipoparatireoidismo

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. A maternal exon H splice-site variant leading to pseudohypoparathyroidism type 1B with broad methylation defects in GNAS-differentially methylated regions.
    Clinical epigenetics· 2026· PMID 41840633mais citado
  2. Adult-onset pseudohypoparathyroidism type 1B diagnosed by methylation analysis: A case report and diagnostic considerations.
    Medicine· 2026· PMID 41824862mais citado
  3. Automated bone age assessment in rare pediatric growth disorders: a comparative study using Deeplasia.
    Frontiers in endocrinology· 2026· PMID 41727682mais citado
  4. Cerebral Calcification and Treatment-Resistant Seizures: A Rare Syndromic Presentation of Pseudohypoparathyroidism-A Case Report.
    AACE endocrinology and diabetes· 2026· PMID 41641299mais citado
  5. Three-generation familial transmission of a GNAS variant: from gestational phenotype in the mother to evolving prenatal/neonatal phenotype in the offspring.
    Hormones (Athens, Greece)· 2026· PMID 41222894mais citado
  6. Pseudohypoparathyroidism in a Chinese girl: A case report.
    J Int Med Res· 2026· PMID 41968081recente
  7. Clinical picture of early infancy PTH resistance syndromes: is it time to improve diagnostic criteria?
    J Clin Endocrinol Metab· 2026· PMID 41964640recente
  8. [Clinical and genetic characteristics of pseudohypoparathyroidism type 1].
    Zhonghua Yi Xue Za Zhi· 2026· PMID 41946590recente
  9. From hypercalcemia to the diagnosis of pseudohypoparathyroidism type 1b: a case report.
    Front Endocrinol (Lausanne)· 2026· PMID 41884215recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:97593(Orphanet)
  2. MONDO:0019992(MONDO)
  3. GARD:10758(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q819207(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Pseudohipoparatireoidismo
Compêndio · Raras BR

Pseudohipoparatireoidismo

ORPHA:97593 · MONDO:0019992
Prevalência
1-9 / 1 000 000
Herança
Autosomal dominant, Not applicable
CID-10
E20.1 · Pseudohipoparatireoidismo
CID-11
Ensaios
9 ativos
Início
All ages
Prevalência
0.67 (Italy)
MedGen
UMLS
C0033806
Repurposing
2 candidatos
calcitriolvitamin D receptor agonist
ergocalciferolvitamin analog
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades